Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Medarex and Neuro Therapeutics enter alliance to develop antibody therapeutics

April 30, 2001

NeoTherapeutics receives U.S. patent for technology with broad therapeutic applications

April 30, 2001

m-phasys enters three important drug discovery alliances

April 25, 2001

Lion Bioscience reaches milestone in drug target alliance with Bayer

April 23, 2001

Samaritan to acquire exclusive worldwide rights to Georgetown technologies

April 23, 2001

Lexicon Genetics scales up gene knockout program

April 20, 2001

Human antibody alliance expanded by Abgenix and Chiron

April 10, 2001

Amsterdam biotechnology company licenses DKFZ's AAV vector technology

April 10, 2001

Novel probes for the dopamine transporter designed at NIDA

April 9, 2001

Genetronics reports promising results from phase II trials of EPT technology

April 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...